Samuel Waxman, M.D., is a distinguished oncologist/hematologist who has dedicated his career to developing minimally toxic cancer therapies. His work focuses on reprogramming cancer cells to behave like normal cells, a less toxic approach that has yielded significant breakthroughs. A key achievement includes his collaborative role in finding a cure for acute promyelocytic leukemia (APL), transforming its prognosis from 100% fatal to 95% survival, for which he received China’s prestigious Friendship Award. An author of over 250 scientific papers and Professor Emeritus at the Icahn School of Medicine at Mount Sinai, his contributions have been recognized with multiple honorary doctorates and induction into the New York Magazine Hall of Fame in Medicine.
In 1976, Dr. Waxman founded the Samuel Waxman Cancer Research Foundation (SWCRF), which pioneered a collaborative “Institute Without Walls” and awarded over $120 million to more than 200 researchers globally. Dr. Waxman has also been a leader in establishing the link between aging and cancer, launching international networks and partnerships to advance research in this critical area.